Recent Updates
Recently added Catalysts

BXT-51072

Phase 2

Acute Coronary Syndrome | Small Molecules | Cardiovascular |SYNVISTA THERAPEUTICS, INC|Trials Updated: Aug 25, 2008

BXT-51072 development status

Highest phase Phase 2
Registered trials 1 across 1 sponsor since May 2006

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindUNCONTROLLED
Total Trials1
Total Enrollment60

FDA Designations

No designations recorded

BXT-51072 clinical trials

BXT-51072 · 1 trial · 2 indications

Phase 2 1
NCT00320502A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)Acute Coronary Syndrome
COMPLETED60 Analytics
PHASE2COMPLETED
A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)
Acute Coronary Syndrome
NCT0032050260
Unlock trial analytics

Study Endpoints

Primary Endpoints

Change in CK-MB
Safety

Secondary Endpoints

Change in troponin
Myocardial ischemia by 24-hour continuous 12-lead ECG
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeTREATMENT

Interventions

NameTypeDescription
BXT-51072DRUG -
Unlock Study Design Details

Eligibility Criteria

Age Range30 Years to 75 Years
SexALL
Healthy VolunteersNo
Study Sites4

Inclusion Criteria: * Type 2 diabetes * Scheduled for elective angioplasty with acute coronary syndrome within 72- hours or MI within 7 days Exclusion Criteria: * CK-MB above normal * Elevated troponin not showing a decreasing value * Congestive heart failure * Atrial fibrillation or left bundle ...

Countries:Israel
Unlock Eligibility Criteria

Explore more on BiopharmaWatch

SYNVISTA THERAPEUTICS, INC (SYNI)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with BCompanies A to ZEvery biotech and pharma company we track